IL17A and psoriasis: IL-17, a potent pro-inflammatory cytokine, is central to the pathogenesis of psoriasis, and IL-17 blockers have shown unprecedented success in the treatment of this disease (Lebwohl et al., 2011, Langley et al., 2014, Ratner, 2015).